Challenges and aims

The Medicen Paris Region global competitiveness cluster brings together all the key players in life sciences and healthcare in Paris Region. The cluster's aim is to enhance the competitiveness, visibility and attractiveness of Paris Region internationally, making it one of the major global metropolitan regions in the field of therapeutic innovation in the years ahead.

• to strengthen the industrial fabric in its sector,
• to promote sustainable growth of the public and private scientific platform,
• to promote access to facilities for all those operating in the sector,
• to stimulate the development of close partnerships,
• to establish a pool of high-level expertise,
• to improve the conditions necessary for successful project finance within the cluster,
• to maintain a high level of international visibility for the cluster.

Strategic thrusts

Dedicated to advanced technologies for healthcare, innovative medications and new gene, molecular and cell therapies, the Medicen Paris Region cluster has defined 6 strategic priorities:

Three priority areas in the therapeutic field:

• diseases of the nervous system
• cancer
• infectious diseases

Three priority areas in the technological field:

• molecular and cellular medicine
• biomedical imaging
• drug design science and technology